(Q82999918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

A Maeda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

H Ando

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

T Asai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

H Ishiguro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

N Umemoto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Ohta

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Morishima

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Sumida

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

T Kobayashi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

K Hosohata

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

K Ushijima

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Fujimura

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

22 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

229-233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Cytochrome p-450 polymorphisms and response to clopidogrel

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Genetic determinants of response to clopidogrel and cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Impact of CYP2C19 polymorphisms on the antiplatelet effect of clopidogrel in an actual clinical setting in Japan.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Comparison of human cytochrome P450 inhibition by the thienopyridines prasugrel, clopidogrel, and ticlopidine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Ticlopidine and clopidogrel

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

New criteria for 'obesity disease' in Japan.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Effects of CYP2C19 genotype on outcomes of clopidogrel treatment

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.268

7 January 2021

Identifiers

DOI

10.1038/CLPT.2010.268

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21178986%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference